140 related articles for article (PubMed ID: 34418452)
41. Involvement of the renin-angiotensin system in endogenous central histamine-induced reversal of critical haemorrhagic hypotension in rats.
Jochem J
J Physiol Pharmacol; 2004 Mar; 55(1 Pt 1):39-55. PubMed ID: 15082866
[TBL] [Abstract][Full Text] [Related]
42. Role of histamine in rodent antinociception.
Malmberg-Aiello P; Lamberti C; Ghelardini C; Giotti A; Bartolini A
Br J Pharmacol; 1994 Apr; 111(4):1269-79. PubMed ID: 8032614
[TBL] [Abstract][Full Text] [Related]
43. Effects of tele-methylhistamine and metoprine on plasma levels of histamine and on its elimination from cat plasma.
Irman-Florjanc T
Inflamm Res; 1997 Mar; 46 Suppl 1():S89-90. PubMed ID: 9098780
[No Abstract] [Full Text] [Related]
44. Is histamine an anticonvulsive inhibitory transmitter?
Tuomisto L; Tacke U
Neuropharmacology; 1986 Aug; 25(8):955-8. PubMed ID: 3022184
[TBL] [Abstract][Full Text] [Related]
45. Neuropeptide S attenuates methamphetamine-induced stereotyped behavior in rats.
Li X; Jiang F; Yao K; Yang L; Gao X; Chen H; Wei X; Wu N; Zhou R; Yuan W; Zhang S
Biochem Biophys Res Commun; 2020 Jun; 527(1):98-103. PubMed ID: 32446398
[TBL] [Abstract][Full Text] [Related]
46. Methamphetamine- and 3,4-methylenedioxymethamphetamine-induced behavioral changes in histamine H3-receptor knockout mice.
Okuda T; Zhang D; Shao H; Okamura N; Takino N; Iwamura T; Sakurai E; Yoshikawa T; Yanai K
J Pharmacol Sci; 2009 Oct; 111(2):167-74. PubMed ID: 19783867
[TBL] [Abstract][Full Text] [Related]
47. Role of serine racemase in behavioral sensitization in mice after repeated administration of methamphetamine.
Horio M; Kohno M; Fujita Y; Ishima T; Inoue R; Mori H; Hashimoto K
PLoS One; 2012; 7(4):e35494. PubMed ID: 22530033
[TBL] [Abstract][Full Text] [Related]
48. Mithramycin protects against dopaminergic neurotoxicity in the mouse brain after administration of methamphetamine.
Hagiwara H; Iyo M; Hashimoto K
Brain Res; 2009 Dec; 1301():189-96. PubMed ID: 19748494
[TBL] [Abstract][Full Text] [Related]
49. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.
Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK
Neuropsychopharmacology; 2003 Oct; 28(10):1730-40. PubMed ID: 12865898
[TBL] [Abstract][Full Text] [Related]
50. Effects of two histamine-N-methyltransferase inhibitors, SKF 91488 and BW 301 U, in rodent antinociception.
Malmberg-Aiello P; Lamberti C; Ipponi A; Hänninen J; Ghelardini C; Bartolini A
Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):354-60. PubMed ID: 9089666
[TBL] [Abstract][Full Text] [Related]
51. Interactions between iboga agents and methamphetamine sensitization: studies of locomotion and stereotypy in rats.
Szumlinski KK; Balogun MY; Maisonneuve IM; Glick SD
Psychopharmacology (Berl); 2000 Aug; 151(2-3):234-41. PubMed ID: 10972470
[TBL] [Abstract][Full Text] [Related]
52. Behavioral sensitization and alteration in monoamine metabolism in mice after single versus repeated methamphetamine administration.
Kitanaka N; Kitanaka J; Takemura M
Eur J Pharmacol; 2003 Aug; 474(1):63-70. PubMed ID: 12909196
[TBL] [Abstract][Full Text] [Related]
53. Methamphetamine-induced changes in the striatal dopamine pathway in μ-opioid receptor knockout mice.
Park SW; Shen X; Tien LT; Roman R; Ma T
J Biomed Sci; 2011 Nov; 18(1):83. PubMed ID: 22074218
[TBL] [Abstract][Full Text] [Related]
54. Role of histaminergic neurons in development of epileptic seizures in EL mice.
Yawata I; Tanaka K; Nakagawa Y; Watanabe Y; Murashima YL; Nakano K
Brain Res Mol Brain Res; 2004 Dec; 132(1):13-7. PubMed ID: 15548424
[TBL] [Abstract][Full Text] [Related]
55. Molecular hydrogen attenuates methamphetamine-induced behavioral sensitization and activation of ERK-ΔFosB signaling in the mouse nucleus accumbens.
Wen D; Hui R; Liu Y; Luo Y; Wang J; Shen X; Xie B; Yu F; Cong B; Ma C
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109781. PubMed ID: 31629777
[TBL] [Abstract][Full Text] [Related]
56. Dopamine D
Tu G; Ying L; Ye L; Zhao J; Liu N; Li J; Liu Y; Zhu M; Wu Y; Xiao B; Guo H; Guo F; Wang H; Zhang L; Zhang L
Biol Psychiatry; 2019 Dec; 86(11):820-835. PubMed ID: 31060803
[TBL] [Abstract][Full Text] [Related]
57. Mice deficient in protein tyrosine phosphatase receptor type Z (PTPRZ) show reduced responsivity to methamphetamine despite an enhanced response to novelty.
Fujikawa A; Noda Y; Yamamoto H; Tanga N; Sakaguchi G; Hattori S; Song WJ; Sora I; Nabeshima T; Katsuura G; Noda M
PLoS One; 2019; 14(8):e0221205. PubMed ID: 31430310
[TBL] [Abstract][Full Text] [Related]
58. L-tetrahydropalmatine inhibits methamphetamine-induced locomotor activity via regulation of 5-HT neuronal activity and dopamine D3 receptor expression.
Yun J
Phytomedicine; 2014 Sep; 21(11):1287-91. PubMed ID: 25172791
[TBL] [Abstract][Full Text] [Related]
59. Effects of dopamine antagonists on neuronal histamine release in the striatum of rats subjected to acute and chronic treatments with methamphetamine.
Ito C; Onodera K; Sakurai E; Sato M; Watanabe T
J Pharmacol Exp Ther; 1996 Oct; 279(1):271-6. PubMed ID: 8859003
[TBL] [Abstract][Full Text] [Related]
60. Lithium attenuates methamphetamine-induced hyperlocomotion and behavioral sensitization via modulation of prefrontal monoamine release.
Ago Y; Tanaka T; Kita Y; Tokumoto H; Takuma K; Matsuda T
Neuropharmacology; 2012 Mar; 62(4):1634-9. PubMed ID: 22001792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
